Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2026-01-03 @ 3:00 AM
Study NCT ID:
NCT05631002
Status:
UNKNOWN
Last Update Posted:
2022-11-30
First Post:
2022-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Chemical Shift Encoding-based Water-fat Magnetic Resonance Imaging in Spinal Tumors
Sponsor:
Peking University Third Hospital
Organization:
Study Overview
Official Title:
Chemical Shift Encoding-based Water-fat Magnetic Resonance Imaging in Spinal Tumors
Status:
UNKNOWN
Status Verified Date:
2022-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Fat composition of the spinal tumors is positively correlated with classification and differential diagnosis of benign and malignant tumors.
Detailed Description:
Chemical shift encoding-based water-fat magnetic resonance imaging (MRI) is a non-invasive method that provides quantitative information about the biochemical water-fat composition of bone marrow and skeletal muscle in vivo.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: